BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36043734)

  • 1. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
    Massaro L; Raguzzini A; Aiello P; Valencia DV
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.
    Alam MA; Subhan N; Rahman MM; Uddin SJ; Reza HM; Sarker SD
    Adv Nutr; 2014 Jul; 5(4):404-17. PubMed ID: 25022990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
    Yang Y; Trevethan M; Wang S; Zhao L
    J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of naringenin and naringin on the glucose uptake and AMPK phosphorylation in high glucose treated HepG2 cells.
    Dayarathne LA; Ranaweera SS; Natraj P; Rajan P; Lee YJ; Han CH
    J Vet Sci; 2021 Nov; 22(6):e92. PubMed ID: 34854271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
    Joshi R; Kulkarni YA; Wairkar S
    Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
    Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
    Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of the adipogenic gene expression by naringenin and naringin in 3T3-L1 adipocytes.
    Dayarathne LA; Ranaweera SS; Natraj P; Rajan P; Lee YJ; Han CH
    J Vet Sci; 2021 Jul; 22(4):e55. PubMed ID: 34313040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis.
    Mulvihill EE; Burke AC; Huff MW
    Annu Rev Nutr; 2016 Jul; 36():275-99. PubMed ID: 27146015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
    Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
    Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrus flavonoids and lipid metabolism.
    Assini JM; Mulvihill EE; Huff MW
    Curr Opin Lipidol; 2013 Feb; 24(1):34-40. PubMed ID: 23254473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+/-)-naringenin.
    Orallo F; Camiña M; Alvarez E; Basaran H; Lugnier C
    Planta Med; 2005 Feb; 71(2):99-107. PubMed ID: 15729616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nutraceutical potential of Lepidium sativum L. seed flavonoid-rich extract in managing metabolic syndrome components.
    L'hadj I; Azzi R; Lahfa F; Koceir EA; Omari N
    J Food Biochem; 2019 Mar; 43(3):e12725. PubMed ID: 31353542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review on the Pharmacokinetic Properties of Naringin and Its Therapeutic Efficacies in Respiratory Diseases.
    Zeng X; Su W; Liu B; Chai L; Shi R; Yao H
    Mini Rev Med Chem; 2020; 20(4):286-293. PubMed ID: 32134369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits.
    Hsiu SL; Huang TY; Hou YC; Chin DH; Chao PD
    Life Sci; 2002 Feb; 70(13):1481-9. PubMed ID: 11895099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Effects of Citrus Flavonoids Neohesperidin, Hesperidin and Its Aglycone, Hesperetin on Bone Health.
    Ortiz AC; Fideles SOM; Reis CHB; Bellini MZ; Pereira ESBM; Pilon JPG; de Marchi MÂ; Detregiachi CRP; Flato UAP; Trazzi BFM; Pagani BT; Ponce JB; Gardizani TP; Veronez FS; Buchaim DV; Buchaim RL
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol.
    Den Hartogh DJ; Tsiani E
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30871083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review.
    Memariani Z; Abbas SQ; Ul Hassan SS; Ahmadi A; Chabra A
    Pharmacol Res; 2021 Sep; 171():105264. PubMed ID: 33166734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits.
    Lee CH; Jeong TS; Choi YK; Hyun BH; Oh GT; Kim EH; Kim JR; Han JI; Bok SH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):681-8. PubMed ID: 11396955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet.
    Pu P; Gao DM; Mohamed S; Chen J; Zhang J; Zhou XY; Zhou NJ; Xie J; Jiang H
    Arch Biochem Biophys; 2012 Feb; 518(1):61-70. PubMed ID: 22198281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.